Genovis carries out new share issue
•New share issue of SEK 7 million with preferential rights to existing shareholdes. •Two (2) shares give right to subscribe to one (1) new share at issue price of SEK 1. •Subscription period 16-30 September. •The company anticipates issue guarantees amounting to SEK 2.5 million.Background and motive The Genovis research and development programme has during 2008 and 2009 given priority to projects focusing on medical-technical use of nanoparticles. The projects have progressed according to plan. To strengthen the accumulated know-how concerning design of nanoparticles, and to transfer the